Drug Shortage Report for DIPHENIST
Report ID | 199745 |
Drug Identification Number | 02219336 |
Brand name | DIPHENIST 50MG/ML |
Common or Proper name | Diphenhydramine Hydrochloride Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DIPHENHYDRAMINE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 x 1 mL vial / fiole |
ATC code | R06AA |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-07-21 |
Estimated end date | 2023-08-31 |
Actual end date | 2023-08-31 |
Shortage status | Resolved |
Updated date | 2023-09-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-07-21 | English | Compare |
v2 | 2023-07-21 | French | Compare |
v3 | 2023-07-22 | English | Compare |
v4 | 2023-08-31 | English | Compare |
v5 | 2023-08-31 | French | Compare |
v6 | 2023-09-01 | English | Compare |
Showing 1 to 6 of 6